EUVIMEDEUVIMED entdecken
Crossref

Is the ganglion cell layer thickness to macular thickness ratio a new biomarker for multiple sclerosis?

Nuray Can Usta, Betul Onal Gunay

International Ophthalmology · 2023

DOI: 10.1007/s10792-023-02839-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2023. Verfasst von Nuray Can Usta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Trabzon Kanuni Training and Research Hospital, University of Health Sciences, Inonu Mah., Maras Cad., Ortahisar, Trabzon, Tu…. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Multiple Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Ganglion cell layer thickness (GCLT)-to-total macular thickness (MT) is a new parameter that has not been studied in multiple sclerosis (MS) before. The current study aims to reveal the status of the GCLT-to-MT ratio in MS and its role in supporting the diagnosis of MS. METHODS: In this retrospective and cross sectional study, the medical records of the MS patients between January 2016 and December 2021 were reviewed. Age-sex matched healthy control group was generated. Demographic and clinical data recorded. All participants were examined using a spectral-domain optic coherence tomography (OCT) device. Retinal layers, choroidal thickness (CT) was recorded. GCLT-to-MT ratio was calculated. RESULTS: A total of 74 eyes of 37 MS (9 male,28 female) patients and 82 eyes of 41 control (13 male, 28 female) were included in the study. The mean age was 37 ± 9.0 (years) in MS group. The MS patients and the control group were compared in terms of OCT parameters, CT was thicker at all regions in MS patients (p < 0.001). Macular thickness, GCLT, and inner plexiform layer thickness (IPLT) were thinner than the control group (p < 0.05). For distinguishing MS patients from healthy subjects, AUROC values for central GCLT/MT, temporal GCLT/MT, superior GCLT/MT, nasal GCLT/MT, and inferior GCLT/MT were 0.717, 0.689, 0.694, 0.733, and 0.740, respectively. CONCLUSIONS: In conclusion MT, GCLT, and IPLT thickness were thinner in MS patients, regardless of optic neuritis. The AUROC values of GCLT/MT were high and GCLT/MT ratio may be a helpful modality in demonstrating retinal neurodegeneration in MS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Ganglion CellsMultiple SclerosisHumansMaleFemaleAdultMiddle AgedRetrospective StudiesCross-Sectional StudiesTomography, Optical Coherence

Stichwörter der Autor:innen

Choroidal thicknessGanglion cell layer thickness-to-macular thicknessMultiple sclerosisOptic coherence tomographyRetinal layers

Autor:innen und Institutionen

  • Department of Neurology, Trabzon Kanuni Training and Research Hospital, University of Health Sciences, Inonu Mah., Maras Cad., Ortahisar, Trabzon, Turkey. dr.nuraycan@hotmail.com.
  • Department of Ophthalmology, Trabzon Kanuni Training and Research Hospital, University of Health Sciences, Ortahisar, Trabzon, Turkey.

Zitieren

APA

Usta, N. C., & Gunay, B. O. (2023). Is the ganglion cell layer thickness to macular thickness ratio a new biomarker for multiple sclerosis?. International Ophthalmology. https://doi.org/10.1007/s10792-023-02839-3

Vancouver

Usta NC, Gunay BO. Is the ganglion cell layer thickness to macular thickness ratio a new biomarker for multiple sclerosis?. International Ophthalmology. 2023. doi:10.1007/s10792-023-02839-3

BibTeX
@article{Usta2023,
  author = {Usta, Nuray Can and Gunay, Betul Onal},
  title = {Is the ganglion cell layer thickness to macular thickness ratio a new biomarker for multiple sclerosis?},
  journal = {International Ophthalmology},
  year = {2023},
  doi = {10.1007/s10792-023-02839-3}
}
Kostenlos starten →